OnKure Therapeutics, Inc.
Stock Chart, Company Information, and Scan Results
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
OnKure Therapeutics, Inc. Company Information, Fundamentals, and Technical Indicators
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.
OnKure Therapeutics, Inc. In Our Stock Scanner
As of Mar 30, 2026Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.